Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma
Article in Nature Communications (April 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Article in Nature Communications (April 2024)
Article in Cell Reports Medicine (March 2024)
Article in Medicine (October 2023)